Skip to main content

Advertisement

Table 3 Summary statistics of the socio-demographic and cytology outcomes of women who received first CCS in an opportunistic cervical cancer screening program in Jos Nigeria (N = 14,088)

From: HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysis

CharacteristicsDescriptive statistics (Mean ± SD, Median, IQR or % in parentheses)95% Confidence intervals
Age at CCS37; IQR, 30–45 
Age groups at CCS
 < 21 years1.11.0, 1.3
 21–3024.724.0, 25.4
 31–4037.336.5, 38.1
 41–5025.424.6, 26.1
 51–608.98.5, 9.4
 61–702.11.8, 2.3
 ≥ 710.20.2, 0.3
 Missing0.20.2, 0.3
Age at first sex20; IQR, 18–22 
Education years completed13; IQR, 12–14 
Annual household income in USD3300; IQR, 1920-4800 
HIV status
 Infected703 (5.0)4.6–5.5
 Not infected13,155 (93.4)93.0–93.8
 Unknown (missing)230 (1.6)1.4–1.9
History of Vaginal infection
 Yes80.079.4–80.7
 No16.616.0–17.2
 Missing3.43.1–3.7
Use of condoms  
 Yes7.46.8–7.6
 No86.285.6–86.8
 Missing6.66.2–7.1
Ever diagnosed with an STI  
 Yes10.09.5–10.5
 No60.860.0–61.6
 Missing29.328.5–30.0
Types of STIs
 Gonorrhea17.014.0–20.5
 Trichomonads6.74.8–9.2
 Hepatitis40.536.4–44.8
 Chlamydia28.717.3–47.1
 HPV/Genital warts5.94.2–8.3
 Syphilis4.83.3–7.0
 Herpes3.42.2–5.4
 PID/Unspecified18.315.6–22.3
# of Lifetime sex partners2; IQR, 1–3 
Parity3; IQR, 2–3 
History of smoking
 Yes0.60.5–0.7
 No98.598.3–98.7
 Missing1.00.8–1.1
History of Alcohol
 Yes6.56.1–6.9
 No92.592.1–93.0
 missing1.00.9–1.2
Race
 Black99.799.6–99.8
 Others0.10.1–0.2
 Missing0.20.1–0.30
Cytology outcome at CCS
 NILM85.785.1–86.3
 ASCUS4.13.8–4.5
 LSIL5.65.3–6.0
 ASC-H1.61.4–1.8
 AGUS0.20.2–0.3
 HSIL2.52.3–2.8
 HSIL, suspicion for invasion0.20.2–0.3
Cytology category at CCS
 Normal cervical cytology85.785.1–86.3
 Mild cervical dysplasia9.79.3–10.2
 Severe cervical dysplasia4.64.2–4.9
  1. SD standard deviation, IQR Interquartile range, % (Percent)